SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes.

Clinical Science
Erik J M van BommelDaniël H van Raalte

Abstract

Sodium-glucose transporter (SGLT)2 inhibitors increase plasma magnesium and plasma phosphate and may cause ketoacidosis, but the contribution of improved glycemic control to these observations as well as effects on other electrolytes and acid-base parameters remain unknown. Therefore, our objective was to compare the effects of SGLT2 inhibitors dapagliflozin and sulfonylurea gliclazide on plasma electrolytes, urinary electrolyte excretion, and acid-base balance in people with Type 2 diabetes (T2D). We assessed the effects of dapagliflozin and gliclazide treatment on plasma electrolytes and bicarbonate, 24-hour urinary pH and excretions of electrolytes, ammonium, citrate, and sulfate in 44 metformin-treated people with T2D and preserved kidney function. Compared with gliclazide, dapagliflozin increased plasma chloride by 1.4 mmol/l (95% CI 0.4-2.4), plasma magnesium by 0.03 mmol/l (95% CI 0.01-0.06), and plasma sulfate by 0.02 mmol/l (95% CI 0.01-0.04). Compared with baseline, dapagliflozin also significantly increased plasma phosphate, but the same trend was observed with gliclazide. From baseline to week 12, dapagliflozin increased the urinary excretion of citrate by 0.93 ± 1.72 mmol/day, acetoacetate by 48 μmol/day (IQR 17-13...Continue Reading

Associated Clinical Trials

References

Apr 1, 1975·The Journal of Clinical Investigation·R A DeFronzoP J Davis
Sep 30, 1974·Clinica Chimica Acta; International Journal of Clinical Chemistry·J H HogeC H Gips
Apr 1, 1974·Kidney International·J A Cunarro, M W Weiner
Oct 3, 2001·Physiological Reviews·D Markovich
Jul 20, 2004·Pflügers Archiv : European journal of physiology·Gabrielle Planelles
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Anil V NairJoost G Hoenderop
Jan 28, 2014·The Journal of Clinical Investigation·Aurora MerovciRalph A DeFronzo
Oct 8, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Judith BlaineMoshe Levi
Dec 20, 2014·The Lancet. Diabetes & Endocrinology·Simeon I TaylorKristina I Rother
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
Dec 24, 2015·Diabetes·Lisanne M M GommersJeroen H F de Baaij
May 20, 2016·American Journal of Physiology. Renal Physiology·Lise BankirGilles Crambert
Jun 1, 2016·Journal of Diabetes and Its Complications·Biff F PalmerMatthew R Weir
Aug 11, 2016·Circulation. Heart Failure·Jozine M Ter MaatenJeffrey M Testani
Oct 5, 2016·JCI Insight·Kelli M SasSubramaniam Pennathur
Dec 8, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Anne M KoningHarry van Goor
Mar 4, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Erik J M van BommelDaniel H van Raalte
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Aug 23, 2017·Diabetes & Metabolic Syndrome·T D FilippatosM S Elisaf
Apr 20, 2018·Physiological Reports·Adrian PostStephan J L Bakker
Jul 31, 2018·The Journal of Clinical Endocrinology and Metabolism·Jian-Jun LiuSu Chi Lim
Oct 6, 2018·Diabetes Care·Julio RosenstockBruce A Perkins
Nov 13, 2018·The New England Journal of Medicine·Stephen D WiviottUNKNOWN DECLARE–TIMI 58 Investigators
Dec 15, 2018·Comprehensive Physiology·Jacques TeulonMarc Paulais
Dec 19, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Maarten A de JongMartin H de Borst
Apr 17, 2019·The New England Journal of Medicine·Vlado PerkovicUNKNOWN CREDENCE Trial Investigators
Nov 17, 2019·Nutrients·Donatella GranchiRenata Caudarella
Nov 27, 2019·JBMR Plus·Giuseppe CiancioloGaetano La Manna

❮ Previous
Next ❯

Citations

Oct 17, 2021·Heart Failure Reviews·Paolo SeverinoFrancesco Fedele

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.